SCHEMBL14697288

SCHEMBL14697288

CCC1CCCN1NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790346 0.93 KMT2A (0.42)
Hydrochloric Acid SCHEMBL8792432 0.91 KMT2A (0.41)
SCHEMBL12947562 0.80
SCHEMBL19320670 0.80 ALDH1A1 (0.34)
SCHEMBL12947620 0.80
SCHEMBL8981710 0.77 HDAC8 (0.38)
SCHEMBL8981701 0.77 HDAC8 (0.38)
SCHEMBL14252713 0.77 HDAC8 (0.38)
SCHEMBL3745411 0.74 HTT (0.36)
SCHEMBL3710481 0.74 KMT2A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2892900-B1 PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS PRINCIPIA BIOPHARMA INC (US) 2017-08-16 EP disclosed
WO-2013025628-A1 JANUS KINASE INHIBITOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 2013-02-21 WO disclosed